These results provide the foundation for future studies examining how GC-B increases osteoblast numbers and/or activity as well as whether CNP analogues such as BMN-111, which play a role in GC-B activation, can effectively treat osteoporosis with a possible role in the quality of bone. The gene discussed is CNP; the disease is osteoporosis.